23 January 2017
Shropshire’s acute hospitals will showcase its innovative Cancer App at a prestigious national health conference later this year.
The web App has been developed by The Shrewsbury and Telford Hospital NHS Trust (SaTH), which runs the Royal Shrewsbury Hospital (RSH) and the Princess Royal Hospital in Telford, to help patients understand and monitor the side effects of chemotherapy treatment and the long-term follow-up of prostate cancer.
The App, which was funded by the Lingen Davies Cancer Fund, was launched at RSH last month and those behind the technology will now promote the ground-breaking digital health solution at the International Digital Health and Care Congress event in London on July 11 and 12.
Dr Sheena Khanduri, Clinical Leader for Cancer Services at SaTH, said: “We are delighted to have the opportunity to promote the App at the Digital Health and Care Congress, a really prestigious conference that focuses on enabling patient-centred care through information and technology.
“The App is packed with important information about chemotherapy and advice about when to contact the helpline to ensure patients are seen at the earliest opportunity. It is hoped the technological advance will result in fewer chemotherapy patients being admitted to hospital as an emergency.”
The exciting digital health solution is being produced as a result of extensive consultation with patients and clinicians about the way SaTH can improve the way in which people with cancer can access services.
Dr Khanduri added: “To be told you have cancer and will need chemotherapy is very frightening, and that is why our hospitals are always looking to improve the care we provide for patients and their families.
“The App provides information and importantly it tells a patient when they need to contact us and how they can do so. It empowers patients to take control of their treatment and its effects and will improve access to the right care when needed.”